Reuters UK Business

BRUSSELS (Reuters) -The European Court of Justice on Friday ruled that carmakers like Volkswagen remain liable for using unlawful defeat devices, such as temperature-sensitive emissions software, even if the vehicles met EU standards, which doesn’t guarantee the technology’s legality. The case at the European Union’s top court arose from two German lawsuits involving Volkswagen diesel …

Volkswagen liable for defeat devices, top EU court rules Read More »

(Reuters) -German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 billion) in provisions to address ongoing litigation in the United States over weed killer Roundup. The German group said that, on a currency-adjusted basis, it now anticipates annual sales of 46 billion euros to 48 …

Bayer adds $1.37 billion to Roundup litigation reserves, raises 2025 sales forecast Read More »

By John Revill and Olivia Le Poidevin RUETLI, Switzerland (Reuters) -Swiss manufacturers warned on Friday that tens of thousands of jobs were at risk after U.S. President Donald Trump hit them with one of the highest tariff rates in his global trade reset, even if there was some relief for now for the key drugs …

Swiss stunned by US tariff hike, seek negotiated solution Read More »

(Reuters) -Healthcare shares led British equities lower on Friday, as U.S. President Donald Trump slapped fresh levies on dozens of countries and demanded lower prescription drug prices. The blue-chip FTSE 100 fell 0.7%, its biggest drop in percentage terms in almost four months, and also snapped a six-week winning streak. The domestically focused midcap FTSE …

Pharma drags London stocks lower after Trump’s tariff blitz Read More »

LONDON (Reuters) -Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna’s patents at London’s Court of Appeal. Last year, the High Court ruled that one of Moderna’s patents relating to the messenger RNA (mRNA) technology which underpinned its COVID-19 vaccine was …

Pfizer, BioNTech lose UK appeal to overturn Moderna’s COVID vaccine patent win Read More »

By Jacob Gronholt-Pedersen (Reuters) -Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent losses that threaten to wipe out all the gains since the drugmaker launched its blockbuster weight-loss treatment Wegovy four years ago. The fall on Friday means the Danish firm has …

Novo Nordisk shares dip further as Wegovy gains nearly erased Read More »

(Reuters) -British scientific instruments maker Spectris <SXS.L> has agreed to private equity firm Advent’s sweetened takeover offer worth 4.8 billion pounds ($6.38 billion), including debt, as the battle for Britain’s biggest takeover target of the year heats up. Shares in the London-headquartered company closed up 2.2% at 4,078 pence, a near four-year high. They have …

UK’s Spectris ditches KKR in favour of Advent’s sweetened $6.4 billion offer Read More »

By Abhinav Parmar (Reuters) -Farm and construction equipment maker CNH Industrial expects a muted finish to the year due to tariff impacts, despite posting second-quarter results above expectations on Friday. The Basildon, UK-based company said most units sold in the second quarter had limited impact from additional tariffs. The effects will come through more in …

CNH Industrial posts upbeat results, but tariffs cloud the rest of 2025 Read More »